Position in CRSP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$57,734,407
+$7,378,233 QoQ
Shares Held
1,058,570
0.0% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
3.64%
of 13F equity value
Holder Rank
#19
of 521 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEA Management Company, LLC holds $1,505,317,406 across 24 Biotechnology names. CRSP ranks #9 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
13,222,228 | $246,594,552 | |
| 2 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $199,519,627 | |
| 3 | GLUE |
Monte Rosa Therapeutics, Inc.
|
7,692,298 | $186,153,611 | |
| 4 | CELC |
Celcuity Inc.
|
1,710,561 | $178,958,891 | |
| 5 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $164,552,620 | |
| 6 | SVRA |
Savara Inc
|
24,471,264 | $150,742,986 | |
| 7 | ZBIO |
Zenas BioPharma, Inc.
|
4,023,219 | $102,109,298 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
3,969,834 | $67,368,082 |
All Filings in CRSP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,734,407 | 1,058,570 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $50,356,174 | 1,058,570 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $55,511,410 | 1,058,570 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $68,605,921 | 1,058,570 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $77,233,218 | 1,587,854 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $54,034,671 | 1,587,854 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $62,497,933 | 1,587,854 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $74,597,380 | 1,587,854 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $85,759,994 | 1,587,854 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $108,228,128 | 1,587,854 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $99,399,660 | 1,587,854 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $72,072,693 | 1,587,854 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $89,142,123 | 1,587,854 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $71,818,636 | 1,587,854 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $64,546,265 | 1,587,854 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $103,906,630 | 1,590,002 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $96,624,421 | 1,590,002 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $99,804,425 | 1,590,002 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $120,490,351 | 1,590,002 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $177,968,923 | 1,590,002 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $257,405,423 | 1,590,002 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $193,741,743 | 1,590,002 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $243,445,206 | 1,590,002 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $132,987,767 | 1,590,002 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $153,643,926 | 2,090,678 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $88,665,653 | 2,090,678 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||